Skip page top navigationFDA Logo--links to FDA home page Logo of and Link to start page of Office of Regulatory Affairs, U.S. Food and Drug Administration U.S. Food and Drug Administration Office of Regulatory Affairs HHS Logo and link to Department of Health and Human Services website

FDA Home Page | Federal-State | Import Program | Compliance | Inspection | Science | ORA Search

Note: Although this FDA-483 is an accurate representation of the original FDA-483 issued to the firm, it is not an exact copy. Slight modifications to the original FDA-483 have been made to accommodate its conversion to the HTML format. A scanned copy of the original FDA-483 is available in PDF format icon PDF format on this website.

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION

DISTRICT OFFICE ADDRESS AND PHONE NUMBER
550 W. Jackson Blvd.
Suite 1500
Chicago, IL 60661
(312)353-5863		 DATE(S) OF INSPECTION
01/29, 30 & 31/2003
FEI NUMBER
NAME AND TITLE OF INDIVIDUAL TO WHOM REPORT IS ISSUED
TO: Melanie J. Loots, Associate Vice Chancelor
FIRM NAME
University of Illinois @ Urbana-Champaign		 STREET ADDRESS
601 E. St. John Street, 400 Swanland MC-304
CITY, STATE AND ZIP CODE
Champaign, Illinois 61820		 TYPE OF ESTABLISHMENT INSPECTED
Sponsor
DURING AN INSPECTION OF YOUR FIRM, WE OBSERVED:

Failure to adequately monitor INADs submitted to FDA/CVM as follows:

  1. In the role of sponsor submitting INAD [redacted] to the U.S. Food and Drug Administration, the university has not reviewed the protocol used by their Investigator in this study.
  2. In the role of sponsor submitting INAD [redacted] to the U.S. Food and Drug Administration, the university has repeatedly failed to adequately monitor related research to assure the investigator complied with government regulations and the study protocol. This deficiency has resulted in the following:
    1. Sale of 386 investigational hogs for slaughter for food since April 2001 without prior authorization from FDA.
    2. Unauthorized rendering of a pig subject to INAD [redacted] on or about 9/27/2002.
SEE REVERSE OF THIS PAGE EMPLOYEE(S) SIGNATURE [Handwritten Signatures]
Mark G. Peterson
Amey L. Adams
Michele C. McGuinness		 EMPLOYEE(S) NAME AND TITLE (Print or Type)
Mark G. Peterson, Investigator
Amey L. Adams, Biologist
Michele C. McGuinness		 DATE ISSUED

1-31-2003

FORM FDA 483 (8/00)   PREVIOUS EDITION OBSOLETE           INSPECTIONAL OBSERVATIONS

Reverse Text on Page:

The observations of objectional conditions and practices listed on the front of this form are reported:

  1. Pursuant to Section 704(b) of the Federal Food, Drug and Cosmetic Act, or
  2. To assist firms inspected in complying with the Acts and regulations enforced by the Food and Drug Administration.
Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21 USC374(b)) provides:

"Upon completion of any such inspection of a factory, warehouse, consulting laboratory, or other establishment, and prior to leaving the premises, the officer or employee making the inspection shall give to the owner, operator, or agent in charge a report in writing setting forth any conditions or practices observed by him which, in his judgement, indicate that any food, drug, device, cosmetic in such establishment (1) consists in whole or in part of any filthy, putrid, or decomposed substance or (2) has been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health. A copy of such report shall be sent promptly to the Secretary."


Web page created by ORA Web Team 12/20/2002